Picture of Fortress Biotech logo

FBIO — Fortress Biotech News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Fortress Biotech Inc reports results for the quarter ended September 30 - Earnings Summary

* Fortress Biotech Inc  FBIO.OQ  reported a quarterly
adjusted
loss of 76 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -94 cents.  The mean expectation of
three analysts for the quarter was for a loss of 59 cents per
share. Wall Street expected results to range from -92 cents
to -27 cents per share.
    * Revenue fell 57.9% to $14.63 million from a year ago;
analysts
expected $32.22 million. 
    * Fortress Biotech Inc's reported EPS for the quarter was a
loss
of 76 cents​.
    * The company reported a quarterly loss of $12.87 million.
    * Fortress Biotech Inc shares had risen by 8.7% this
quarter and
lost 47.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 47.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Fortress Biotech
Inc is $13.00 
This summary was machine generated from LSEG data November 15 at
02:10 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.59          -0.76          Missed
 Jun. 30 2024      -1.22          -0.73          Beat
 Mar. 31 2024      -1.73          -1.03          Beat
 Dec. 31 2023      -1.97          -1.28          Beat

Recent news on Fortress Biotech

See all news